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Abstract
The time course of dark adaptation was
measured in 10 subjects from three families
with autosomal dominant sector retinitis
pigmentosa (RP) due to mutations in the first
exon of the rod opsin gene. In each subject
cone adaptation and the early part of the
recovery ofrod sensitivity followed the normal
time course, but the later phase of rod
adaptation was markedly prolonged. The
recovery ofrod sensitivity is much slower than
that reported in any other outer retinal
dystrophy. Using a model based upon primate
data ofrod outer segment length and turnover,
we have calculated that the delayed phase of
the recovery of rod sensitivity in the RP
patients testedfollowingstronglight adaptation
could be due in part to formation of new disc
membrane with its normal concentration of
rhodopsin rather than in situ regeneration of
photopigment.
(BrJ7 Ophthalmol 1992; 76: 465-469)
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Research into disease mechanisms in retinitis
pigmentosa (RP) is complicatfd by heterogeneity
within the disorder. RP may be inherited as an
autosomal dominant, autosomal recessive, or X-
linked disorder, and there is good evidence of
heterogeneity within genetic subtypes.'-'3
Further subdivision of autosomal dominant RP
(ADRP) has been achieved by analysis of
functional deficits. Two broad categories of RP
have been identified which are designated as
class I or 'diffuse' and class II or 'regional'
forms," and the functional characteristics
appear to be consistent within families indicating
that the functional differences reflect genetic
heterogeneity. An additional variant, sector
RP is characterised by retinal atrophy seen in
only one part of the fundus, usually the lower
nasal quadrant, and gross field loss confined to
the area of visual field corresponding to the
involved retina. The rod and cone electroretino-
graphs show mild reduction in amplitude with
normal cone implicit times. 7 This pattern of
disease is seen in all affected family members,
irrespective of age suggesting that the disease, in
contrast to other forms of ADRP, is non-
progressive or progresses very slowly.
Recent genetic studies have provided evidence
for further heterogeneity in AD and X-linked
RP."'2 About 25% of families with ADRP show
mutations of the rod opsin gene on chromosome
3,131 4 and among this group of patients different
patterns of retinal dysfunction may be seen with
different mutations.'"'0 Recently it has been
shown that genes other than that for rod opsin
may transmit ADRP.2 24
Here we report the clinical, electroretino-
graphic, and psychophysical findings in 10
patients from three families with autosomal
dominant sector RP due to mutations in the rod
opsin gene. In each of these families there was
markedly slowed rod adaptation.
Patients and methods
Ten affected individuals from three families
diagnosed as having sector ADRP were studied
(Table 1). Informed consent was obtained after
the nature of the procedure had been fully
explained. In each patient ophthalmoscopy
revealed pigment epithelial atrophy and pigment
migration into the lower retina which was most
marked in the inferior nasal quadrant. The
upper retina had a normal appearance. In each
case Goldmann perimetry revealed upper field
loss corresponding to the ophthalmoscopically
abnormal retina (Fig 1). Electroretinography
was performed in nine subjects in accordance
with a standard protocol25 (Table 2). Dark
adapted perimetry was performed on the right
eye of each subject using red (dominant wave-
length 660 nm, subtending 0.90) and green
(dominant wavelength 530 nm, subtending 0.90)
targets. The pupil was dilated with 1% cyclo-
pentolate and the eye dark adapted for 40
minutes before starting the test. At least 17
points at different retinal locations in both upper
and lower fields were tested in each case. The
apparatus and method for the dark adapted static
perimetry have been described previously.26
Dark adaptation curves were obtained from
threshold measurements determined using the
green (530 nm, 0 9°) target ofthe static perimeter
or the Tubinger perimeter (dominant wave-
length 500 nm; stimulus size 1-70). We chose to
determine the dark adaptation curves at points in
the clinically uninvolved retina where the rod
threshold elevations were less marked (Table 1).
Threshold measurements were made on the right
eye. The pupil was dilated, the eye dark adapted
for 60 minutes, and a dark adapted threshold was
then determined. The area of retina to be tested
was then fully light adapted (7 5 log scotopic
trolands for 3 seconds) and measurements were
continued in the dark for at least 60 minutes (or
longer if the patient could tolerate it).
Blood samples were collected from each
subject and DNA extracted. Exon sequences
were amplified using the polymerase chain
reaction (PCR) and screened for mutations using
the heteroduplex assay as described pre-
465
Moore, Fitzke, Kemp, Arden, Keen, Inglehearn, Bhattacharya, Bird
Table I Pre-bleach thresholds and elevation ofthreshold after 60 minutes ofdark adaptation
following strong light adaptation. In families 1038 and 1084 the mutation is Glyl06Arg, and
in 1935 it is Thr58Arg
DA threshold Additional threshold
Subject RPfamily Age Test location elevation elevationa
1 1038 36 180M25E 0-8 1 0
2 1038 64 330M25E 1.1 1-2
3 1038 74 315M20E 1.9* 1.1*
4 1084 26 180M 25E 0 9 1-6
5 1084 47 345M25E 1.1 1.0
6 1935 45 315M 40E 0-6* 0-8*
315M50E 0.5* 0.4*
7 1935 18 180M25E 0.1 1.9
180M 40E 0.0 1-4
8 1935 16 180M40E 1.1 1-6
9 1935 21 315M 30E 0.0 1-3
10 1935 50 315M 40E 1-5* 1-4*
315M 50E 1-5* 2-1*
aAdditional threshold elevation=the elevation over the dark adapted threshold after 60 minutes of
adaptation following bleach.
DA=dark adapted; M=meridian; E=eccentricity measured in degrees. Thresholds were measured
with a LED adaptometer*, or Tubinger perimeter.
Table 2 Amplitudes and implicit times ofthe electroretinograms
Subject Dark adapted blue Brightflash white Flicker (30 Hz)
Eye Age b amp b imp a amp a imp b amp b imp b amp b imp
1 R 36 220 60 160 24 360 50 35 30
L 200 60 120 24 340 50 40 30
3 R 74 200 80 140 26 260 64 10 40
L 180 80 100 27 200 56 15 40
4 R 26 280 60 200 13 420 60 50 30
L 240 60 160 13 400 60 50 30
5 R 47 320 60 160 20 300 50 50 30
6R 45 110 62 80 22 140 51 20 32
L 115 70 80 22 140 56 20 33
7 R 18 170 74 120 22 280 50 35 30
L 160 74 160 22 280 50 45 30
8 R 16 230 68 140 22 280 60 100 30
L 200 68 160 22 320 60 80 30
9 R 21 170 80 50 22 230 50 25 32
L 100 70 60 22 160 50 35 32
1OR 50 100 84 55 24 180 54 12 34
L 80 84 60 24 140 55 11 36
Normal values
319 57 264 15 404 50 43 29
(1 SD) (89) (6) (64) (2 5) (88) (3) (5) (1 5)
amp=amplitude in RV; imp=implicit time in milliseconds; no data are available on subject 2.
viously.'728 Pairs of oligonucleotide primers were
synthesised surrounding rod opsin exons to give
PCR products in the range of 200-300 bp. The
PCR was carried out using a two-stage reaction
profile of 94°C for 30 seconds and 60°C for 3
minutes, repeated 30 times. Aliquots of the PCR
reactions mixes were then electrophoresed on D-
5000 hydrolink gels (AT Biochem, Malvern, PA,
USA for around 2000 Vh). Mismatches due to
the presence of a heterozygous mutation caused
shifted mobility in heteroduplexed molecules,
which could then be further characterised by
sequencing the appropriate PCR product.
Results
Rod opsin mutations were identified in each
family comprising a change of threonine to
arginine at codon 58 in RP1935, and glycine to
arginine at codon 106 in RP1038 and RP1084.
Both mutations can be detected as altered restric-
tion sites in PCR amplified rod opsin exon 1
(Fig 2).
In all subjects Goldmann visual field loss was
confined to the upper field, and dark adapted
perimetry confirmed that thresholds for both the
530 nm and 660 nm targets were markedly
elevated throughout that region (Fig 1). In the
lower field, which was normal on Goldmann
perimetry, dark adapted perimetry was normal
in some areas but mildly abnormal in others
Figure I Patient 1: right eye, Goldmann visualfields to
IV4e (solid line) and IL4e (broken line) targets. Numerical
values indicate dark adapted static perimetry threshold
elevation in tenths ofa log unit to a green (530 nm) target).
consistent with the regional pattern of disease.
This pattern of threshold elevation was a con-
sistent finding in all 10 subjects.
All subjects had normal or-mildly reduced rod
and cone b-wave amplitudes of the ERG (Table
2). There was a trend for the amplitudes to
become less with age but they did not approach
the levels seen in non-sector RP. Rod b-wave
implicit times were abnormal in all five members
of RP1935 and the oldest member of RP1038.
Cone implicit times were normal in at least one
member of each family.
Dark adaptation was markedly prolonged in
all 10 subjects, and none reached their pre-
bleach threshold by 60 minutes. At this time the
threshold elevation relative to the pre-bleach
values ranged from 0 4 to 2a 1 log units (Table 1).
Inspection of the dark adaptation curves showed
that in each case there was a similar pattern of
abnormality; cone adaptation was normal, the
rod cone break occurred at the normal time, and
the early part ofthe rod adaptation curve followed
an apparently normal time course. Subsequently
rod adaptation was markedly slowed with a
gradual drift down towards the threshold (Figs 3
and 4).
Because ofthe difficulty with prolonged testing
it is not possible to give the exact time for full
recovery of rod function. However two subjects
agreed to be tested again during the following
days. At the end of the initial dark adaptation
determinations the subjects returned to normal
ambient lighting conditions, and were later
retested at the same retinal location at periods
ranging from 24 to 120 hours post-bleach. On
each occasion the subjects were dark adapted for
1 hour before threshold measurements were
taken. Subject 10 showed elevated thresholds of
0-6 and 1-4 logs units above pre-bleach values at
two different locations 44 hours after light
adaptation, and in subject 7 the threshold was
elevated 1-5 log units at 24 hours but had
returned to the dark adapted value by 120 hours.
Discussion
Nyctalopia is a prominent and early symptom in
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Figure 2 (A) Family 1935
pedigree, mounted above a
photograph ofan ethidium
bromide stained gel showing
PCR amplified exon I from
members ofthefamily cut
with the enzyme Ddel. PCR
primers CATGTTTCTG
CTGATCGTGC and
ACTCTCCCAGACCCC
TCCAT give a 295 bp
fragment which is normally
uncut with the restriction
enzyme Dde 1. However the
codon 58 ACG toAGG
mutation introduces a Dde I
site, which gives rise to 254
and 41 bp bands. All
affected individuals are
heterozygous for the uncut
and cutfragments. (B)
Family 1038 pedigree,
mounted above a gel picture
showing PCR amplified
exon I fromfamily members
which has been cut with the
restriction enzyme Apal. The
same PCR primers were
used giving afragment of
295 bp, which is normally
cut to 191 and 104 bp
fragments by Apa 1. The
codon 106 GGG toAGG
mutation destroys this site, so
that affected individuals are
again heterozygous for
digested and undigested
product.
RP1935
3
:In
a)
._
0)
0
6
5
4
3
2
.0-w - il - - ,- _-14mmm
Fig 2A
RP1 038
vrs- -r:
Fig 2B
RP, and elevated absolute thresholds are seen in
all types of the disease. Where there is extensive
loss ofrod function, cones may mediate threshold
even under scotopic conditions so that the dark
adaptation curve is monophasic. In patients with
less advanced disease, most studies have
identified a biphasic dark adaptation curve with
a normal time course but elevated final thres-
hold.2930 However, Alexander and Fishman
pointed out that unless a baseline dark adapted
threshold is determined before light adaptation it
is not possible to be certain that dark adaptation
is complete even when thresholds appear to have
stabilised.3" They identified several patients with
different types ofRP in whom the final thresholds
were elevated and the time course of recovery of
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Figure 3 Patient 1: right eye, dark adaptation curve plotted
using Tubinger perimeter (500 nm wavelength) at 25 deg
eccentricity along the horizontal nasalfield meridian. The
patient's threshold values (solid circles) and those oftwo
normal observers (open symbols) are plotted relative to normal
absolute threshold. The patient's baseline dark adapted
threshold is shown as the horizontal line. Adaptation to the
8-0 log scotopic troland seconds light was at time zero.
U 4_-
-10 10
0,
g
a-=1 Pre-bleach threshold
'bff.&l M 4X
30 50 70 90 110
Time (min)
Figure 4 Patient 4: right eye, dark adaptation curve plotted
using the Tubinger perimeter (500 nm wavelength) at 25
degree eccentricity along horizontal nasalfield meridian. The
patient's threshold values (solid circles) and those oftwo
normal observers (open symbols) are plotted relative to normal
absolute threshold. The patient's baseline dark adapted
threshold is shown as the horizontal line. Adaptation to the 8.0
log scotopic troland seconds light was at time zero.
rod sensitivity was slow. They did not determine
that the abnormality was consistently seen
within a family or genetic subtype.
Using a similar approach we have been able to
show delayed rod dark adaptation in all 10
subjects from three families with autosomal
dominant RP. Our patients resemble those
designated as sector RP'-7 in that altitudinal
distribution of disease was found consistently in
each family whatever the age of the subject.
Although the implicit time ofthe rod and cone b-
waves were not normal in all subjects, normal
times were found in at least one member of each
family.
The functional abnormality in our patients
with a mutation at codon 106 is qualitatively
similar to that seen with the mutation at codon
58. Slow rod adaptation has been identified
previously in some patients with ADRP,'9203' 32
including some with altitudinal distribution
of disease and known mutations of the
rod opsin gene namely: threonine-17-methi-
onine19; proline-23-histidine,20 and threonine-
58-arginine.'9 Our results are similar to those
previously reported although the slow phase of
recovery of rod sensitivity was longer in our
patients than in each of the other genotypes.
There is no clear explanation for this disparity
although the light adaptation protocols were
different in that we used more light (8-0 log
scotopic troland seconds as opposed to 7 5), and
it was delivered in a shorter time (3 seconds as
opposed to 60).
There are several possible mechanisims by
which abnormality of the rod opsin molecule
could result in slowed adaptation. There may be
slowed regeneration of rhodopsin as seen in
fundus albipunctatus3334 or delayed removal of
abnormal bleach photoproducts which may
interfere with rhodopsin formation or desensitise
the rod photoreceptors.3'
Alternatively, it is possible that abnormal rod
opsin could interfere with normal disc assembly,
structure, or stability. The prolongation of the
recovery of rod sensitivity to a period of several
days led us to consider whether or not outer
segment renewal may contribute to the later
phase of dark adaptation in our patients. In our
model we have assumed the dark adapted rod
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80 100 120
FigureS Dark adaptation curves measured undersimilar conditions to Figures 2 and3
showing the results from three patients (subjects 1, 4, 8) compared with normal controls (open
symbols). These patients are illustrated since dark adaptation was recordedfor more than 100
minutes. The pre-bleach thresholds are indicated by the horizontal lines. The solid curve
represents the results ofthe calculation of the effect on threshold ofouter segment renewal (see
text).
threshold elevation can be completely accounted
for by reduced levels of rhodopsin causing
decreased absorption of incident quanta pro-
posed in the regional form of disease.4 This
supposition is consistent with the observations of
Kemp et al.20 If there were either no significant
in situ regeneration of rhodopsin after full light
adaptation, or excessive shedding from a
shortened outer segment leaving only a greatly
truncated functioning outer segment, recovery
of rod sensitivity would depend largely on the
formation of new outer segment discs with their
normal concentration of rhodopsin. In favour of
the latter is the suggestion that night blindness in
some forms of RP may be caused by progressive
shortening of the rod outer segment due to an
imbalance between disc shedding and renewal,35
and the identification of shortened rod outer
segments in autosomal dominant RP in a histo-
logical study.2 Using data from primate studies
of rod outer segment length and disc turnover,37
the recovery of rod sensitivity due entirely to
regrowth of photoreceptor discs can be
calculated. It is possible then to model the effect
of different rod outer segment lengths and
different rates of renewal on recovery of rod
sensitivity. Here we have considered a simple
model of an outer segment length of 0 0m1m
following intense light adaptation and assumed
normal outer segment renewal of 3 ,um per day.
The predicted recovery of rod sensitivity with
formation of new outer segment discs can be
calculated using the quantum catch relationship4
(Fig 5). Using this simple model there is a good
fit between the predicted recovery of rod sensi-
tivity and that actually measured in our subjects
during the entire abnormal late phase of rod
adaptation.
Thus, the very slowed late phase of rod dark
adaptation seen in our subjects, may be explained
by the regrowth ofrod outer segments with their
normal concentration of rhodopsin. The data do
not distinguish between the two possible
mechanisms, namely failure to regenerate
rhodopsin on existing outer segment disc
membranes and light induced shedding
restricting available membrane. However the
normal time course of the early phase of recovery
of rod sensitivity is more readily explained by the
second; if shedding were not complete and in situ
regeneration of rhodopsin occurred normally in
the small residual outer segment, initial rod dark
adaptation would be normal as seen in our
patients. The similarity between the recovery of
sensitivity predicted by the model and that seen
in our patients suggests that outer segment
renewal contributes to recovery after light
adaptation in some patients. To date this
mechanism of recovery from strong light
adaptation has received little attention, and is
worthy of further study.
The model requires that the outer segments
are short as a results of RP and that a major
portion of the outer segment is shed following
strong light adaptation. The mechanism by
which alteration of the amino acid sequence of
the rod opsin molecule may influence outer
segment structure or stability remains to be
elucidated. The phenomenon occurs with dif-
ferent mutations in the rod opsin molecule,
although all mutations associated with this
pattern of disease recorded to date are on the first
exon, and it is quite possible that similar func-
tional defects may be found with defects on other
genes.
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